Definitive Contract 75F40122C00145
Award Date 9/26/22
Potential Completion Date 9/26/25
Potential Value $575K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a definitive contract to the Institute for Safe Medication Practices, a 501(c)(3) nonprofit organization. The $209,738.72 contract, which was not set aside, is for the delivery of a Perioperative Medication Safety Self-Assessment for Hospitals and Ambulatory Surgical Centers (ASCs) and Targeted Risk-Reduction Tool Development. Through past prime federal contracts, the Institute for Safe Medication Practices has...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $224,594.36 firm fixed price definitive contract to the National Academy of Sciences, a non-profit organization, for a Geriatric Oncology Workshop in Washington, DC. The contract was awarded on May 5, 2020 and is set to be completed by May 5, 2021. The National Academy of Sciences has experience providing advisory, research, and technical support services to various federal agencies through prime and...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,275,361.26 definitive cost-no-fee contract to Alliance Nctn Foundation, a non-profit organization and foundation, to conduct the "Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Data Capture and Standardization Study". This contract, with a performance period ending on September 29, 2024, is part of the FDA's broader efforts to advance regulatory science and support public...
- The U.S. Food and Drug Administration (FDA) awarded a $515,769.89 firm fixed price definitive contract to the University of St. Gallen, a Swiss educational institution, to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification. This contract was awarded under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research...
- The Department of Health and Human Services Food and Drug Administration awarded a $441,597 firm fixed price definitive contract to the Collaborative Community On Ophthalmic Imaging Foundation. The contract was awarded under Broad Agency Announcement FY23 FDA BAA for Advanced Research and Development of Regulatory Science to support enhancing visual health equity via novel, real-world underserved population health data sets utilizing ophthalmic imaging and artificial intelligence. The place of...
- This is a federal contract award from the Food and Drug Administration (FDA) to Infinisource Consulting Solutions, Inc., a self-certified small disadvantaged, woman-owned, and economically disadvantaged small business. The contract, valued at $515,241.33, provides procurement assistant support services to the FDA's Office of Acquisitions and Grants Services (OAGS). The contract is a delivery order with a labor hours pricing type and has an ultimate completion date of September 1, 2016. This...
- This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
- This is a $381,002 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research institute. The contract is for Good Manufacturing Practice (GMP) manufacturing of the investigational drug oxfendazole for clinical trials, as well as conducting stability studies. The contract was awarded under the Nonclinical Services for Development of...
- The Food and Drug Administration's Center for Devices and Radiological Health awarded a delivery order valued at $150,000 to the National Academy of Sciences (NAS) to establish a forum on temporomandibular disorders. This is a cost-no-fee contract, reflecting NAS's nonprofit status and its role as a trusted scientific advisor to the federal government. The contract was awarded on September 22, 2023, with a no-cost modification issued to extend the period of performance through March 29, 2026. No...
- This $291,142 firm fixed price prime contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the Institute For Clinical Pharmacodynamics, Inc. to conduct research on updating susceptibility guidance for the oral antibiotics sulfamethoxazole-trimethoprim. The contract supports the agency's efforts to develop modernized susceptibility guidance using pharmacometric approaches. No set-aside designation was used for this award. The Institute For Clinical...